AXA IM Alts raises €1.9b for European life sciences investments

AXA IM Alts, the alternative investments manager, has raised €1.9 bn of equity to accelerate investments into the Life Sciences sector.

Would you like to read more? Log in first (top right of the screen) or take a trial.


Latest news

Best read stories